Baxter International BAX is currently in transition following the divestiture of Kidney Care, balancing near-term execution ...
It was reported on January 27, that Roger E Susi, CEO at iRadimed (NASDAQ: IRMD) executed a significant insider sell, according to an SEC filing. What Happened: A Form 4 filing from the U.S.
Future research should focus on testing PVC removal beyond 96 hours, patient preferences for routine or clinically indicated PVC removal, more rigorous studies and use of ultrasound to assess PVC ...
What Happened: Susi's recent move involves selling 5,000 shares of iRadimed. This information is documented in a Form 4 ...
Amivantamab with lazertinib will be made available on the NHS. This will provide a possible treatment for people with a ...
(“RenovoRx” or “the Company”) (Nasdaq: RNXT) , a life-sciences company developing innovative targeted oncology therapies and ...
SurvivorNet on MSN
Targeted drug Epkinly is suddenly front & center in lymphoma care: Here’s what patients need to know
The FDA approved Epkinly in combination with other standard lymphoma drugs, rituximab + lenalidomide, for relapsed or ...
Patients could benefit from the new treatment option ...
Doctors study for years to be able to 'dish out' medical advice. They're trained to know whether or not it's safe for a ...
A novel cancer treatment will be accessible on the NHS following 'careful consideration of the evidence' by the National ...
Lactated Ringers Injection Market to reach USD 2.9 Bn by 2036, driven by rising hospital admissions, increasing surgical ...
The West Texas high school football season produced great moments and performances from local athletes. Here's who we think ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results